| 摘要 |
<p>A nasal spray or nasal drops for the treatment of allergic rhinitis is disclosed comprising: a) an effective amount of a topical mast cell stabilizer to inhibit mast cell mediator release where said topical nasal mast cell stabilizer is selected from the group consisting of cromolyn sodium, nedocromil and lodoxamide; b) an effective amount of a topical nasal steroid to reduce inflammation where said nasal steroid is selected from the group consisting of beclomethasone, flunisolide, triamcinolone, dexamethasone and budesonide; and c) sterile water.</p> |
